NDATOPICALCREAM
Approved
Feb 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
5/8 — Partial
EXELDERM (sulconazole nitrate) by Journey Medical is clinical pharmacology sulconazole nitrate is an imidazole derivative with broad-spectrum antifungal activity that inhibits the growth in vitro of the common pathogenic dermatophytes including trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosum and microsporum canis. Approved for tinea pedis (athlete's foot), tinea cruris, tinea corporis caused by trichophyton rubrum and 4 more indications. First approved in 1989.
Drug data last refreshed 6h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EXELDERM (sulconazole nitrate) is a topical imidazole antifungal cream approved in 1989 for treating dermatophyte infections including tinea pedis, tinea cruris, tinea corporis, and tinea versicolor. It works by inhibiting fungal growth through disruption of cell wall synthesis in common pathogenic fungi such as Trichophyton rubrum and Malassezia furfur.
$0.111MPart D
LOE ApproachingDeclining
Minimal commercial momentum with only $111K in Part D spending signals a contracting brand team and limited growth opportunities; roles are maintenance-focused rather than expansion-driven.
Mechanism of Action
CLINICAL PHARMACOLOGY Sulconazole nitrate is an imidazole derivative with broad-spectrum antifungal activity that inhibits the growth in vitro of the common pathogenic dermatophytes including Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum and Microsporum canis. It also…
Indications (7)
Worked on EXELDERM at Journey Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.